glp 1 agonist drug List of approved and pending GLP-1 medications glp-1 receptor agonist drug names

Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes

however, trials developed mainly to evaluate the long-term impact of tirzepatide on cardiovascular events, including stroke, are currently in progress [42]

doi: 10.3390/metabo13050587

for example, 3 kg weight reduction leads to a marginal improvement in LDL-C and mean reduction in triglycerides of 15 mg/dL, while weight loss of 58 kg, lowers LDL-C on average by 5 mg/dL and increases HDL-C by 3 mg/dL

2017;25:20 Lu Y, Wu L, Lin M, Bao X, Zhong H, Ke P, et al

2025;135(21):e194751